ConvaTec Group Plc
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostom… Read more
ConvaTec Group Plc (CNVVF) - Net Assets
Latest net assets as of June 2025: $1.81 Billion USD
Based on the latest financial reports, ConvaTec Group Plc (CNVVF) has net assets worth $1.81 Billion USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.77 Billion) and total liabilities ($1.96 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.81 Billion |
| % of Total Assets | 48.02% |
| Annual Growth Rate | N/A |
| 5-Year Change | 1.09% |
| 10-Year Change | N/A |
| Growth Volatility | 178.96 |
ConvaTec Group Plc - Net Assets Trend (2012–2024)
This chart illustrates how ConvaTec Group Plc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ConvaTec Group Plc (2012–2024)
The table below shows the annual net assets of ConvaTec Group Plc from 2012 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $1.69 Billion | -0.22% |
| 2023-12-31 | $1.69 Billion | +5.16% |
| 2022-12-31 | $1.61 Billion | -5.02% |
| 2021-12-31 | $1.69 Billion | +1.44% |
| 2020-12-31 | $1.67 Billion | +7.03% |
| 2019-12-31 | $1.56 Billion | -3.48% |
| 2018-12-31 | $1.62 Billion | +6.13% |
| 2017-12-31 | $1.52 Billion | +22.28% |
| 2016-12-31 | $1.25 Billion | +669.56% |
| 2015-12-31 | $-218.80 Million | +1.31% |
| 2014-12-31 | $-221.70 Million | -564.78% |
| 2013-12-31 | $47.70 Million | +102.57% |
| 2012-12-31 | $-1.86 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to ConvaTec Group Plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 136530000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $251.24 Million | 14.88% |
| Other Comprehensive Income | $2.10 Billion | 124.41% |
| Other Components | $164.86 Million | 9.76% |
| Total Equity | $1.69 Billion | 100.00% |
ConvaTec Group Plc Competitors by Market Cap
The table below lists competitors of ConvaTec Group Plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hexcel Corporation
NYSE:HXL
|
$6.08 Billion |
|
GXO Logistics Inc
NYSE:GXO
|
$6.08 Billion |
|
B2Gold Corp
NYSE MKT:BTG
|
$6.09 Billion |
|
Eurofins Scientific SE
PINK:ERFSF
|
$6.09 Billion |
|
KASPI.KZ (SP.GDR REG.S)/1
F:KKS
|
$6.07 Billion |
|
Joby Aviation
NYSE:JOBY
|
$6.07 Billion |
|
MEBUKI FINANCIAL GROUP
F:5EE
|
$6.07 Billion |
|
Unigroup Guoxin Microelectronics Co Ltd
SHE:002049
|
$6.06 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ConvaTec Group Plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,692,700,000 to 1,688,900,000, a change of -3,800,000 (-0.2%).
- Net income of 190,500,000 contributed positively to equity growth.
- Dividend payments of 130,200,000 reduced retained earnings.
- Share repurchases of 10,900,000 reduced equity.
- Other comprehensive income increased equity by 2,050,671,447.
- Other factors decreased equity by 2,103,871,447.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $190.50 Million | +11.28% |
| Dividends Paid | $130.20 Million | -7.71% |
| Share Repurchases | $10.90 Million | -0.65% |
| Other Comprehensive Income | $2.05 Billion | +121.42% |
| Other Changes | $-2.10 Billion | -124.57% |
| Total Change | $- | -0.22% |
Book Value vs Market Value Analysis
This analysis compares ConvaTec Group Plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.65x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | $-18.30 | $3.00 | x |
| 2013-12-31 | $0.43 | $3.00 | x |
| 2014-12-31 | $-1.98 | $3.00 | x |
| 2015-12-31 | $-1.95 | $3.00 | x |
| 2016-12-31 | $0.65 | $3.00 | x |
| 2017-12-31 | $0.78 | $3.00 | x |
| 2018-12-31 | $0.83 | $3.00 | x |
| 2019-12-31 | $0.79 | $3.00 | x |
| 2020-12-31 | $0.83 | $3.00 | x |
| 2021-12-31 | $0.84 | $3.00 | x |
| 2022-12-31 | $0.79 | $3.00 | x |
| 2023-12-31 | $0.82 | $3.00 | x |
| 2024-12-31 | $0.82 | $3.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ConvaTec Group Plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.28%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.32%
- • Asset Turnover: 0.65x
- • Equity Multiplier: 2.08x
- Recent ROE (11.28%) is above the historical average (6.02%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 0.00% | -9.79% | 0.37x | 0.00x | $44.20 Million |
| 2013 | 31.87% | 0.89% | 0.38x | 94.06x | $10.43 Million |
| 2014 | 0.00% | -7.33% | 0.44x | 0.00x | $-105.03 Million |
| 2015 | 0.00% | -5.66% | 0.42x | 0.00x | $-68.22 Million |
| 2016 | -14.90% | -12.01% | 0.44x | 2.82x | $-310.34 Million |
| 2017 | 10.40% | 8.55% | 0.49x | 2.49x | $6.02 Million |
| 2018 | 13.70% | 12.66% | 0.48x | 2.26x | $59.88 Million |
| 2019 | 0.63% | 0.54% | 0.51x | 2.31x | $-146.30 Million |
| 2020 | 6.73% | 5.94% | 0.50x | 2.25x | $-54.57 Million |
| 2021 | 6.94% | 5.77% | 0.55x | 2.17x | $-51.88 Million |
| 2022 | 3.91% | 3.03% | 0.58x | 2.23x | $-98.07 Million |
| 2023 | 7.70% | 6.08% | 0.58x | 2.19x | $-38.97 Million |
| 2024 | 11.28% | 8.32% | 0.65x | 2.08x | $21.61 Million |
Industry Comparison
This section compares ConvaTec Group Plc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ConvaTec Group Plc (CNVVF) | $1.81 Billion | 0.00% | 1.08x | $6.08 Billion |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |